Immunodeficiency and intrinsic IFN resistance are associated with viral breakthrough to HCV therapy in HIV-coinfected patients. [electronic resource]
Producer: 20080128Description: 1354-9 p. digitalISSN:- 0889-2229
- Adult
- Alanine Transaminase -- blood
- Antiviral Agents -- therapeutic use
- Aspartate Aminotransferases -- blood
- CD4 Lymphocyte Count
- Drug Resistance, Viral -- immunology
- Female
- HIV Infections -- complications
- Hepacivirus -- drug effects
- Hepatitis C -- drug therapy
- Humans
- Interferons -- therapeutic use
- Male
- Middle Aged
- Molecular Sequence Data
- Ribavirin -- therapeutic use
- Viral Load
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.